Medical News

RSS

Patient personality can cause missed diagnoses of depression

Patient personality affects the accuracy of reports by friends and family members of mood history and symptoms and can cause missed diagnoses of depression, according to research published online by the journal International Psychogeriatrics.

8 Oct 2010

NIAID announces three new contracts to fund research on dengue, anthrax vaccines

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack. Each project focuses on simple and efficient vaccine delivery approaches that could be deployed quickly. The total funding for the three contracts could reach $68 million, depending on the successful completion of defined project milestones.

8 Oct 2010

New standards for bomb suits

When a bomb technician inspects a potential explosive device, the bulky protective suit might be the only defense he or she has. Bomb suit manufacturers run tests on their protective suits to ensure they can withstand an explosion, but there currently is no single set of requirements that the suits must meet before they can be sold.

8 Oct 2010

Opeds: Editorials weigh in on success -- or not -- of 'Obama's' health reform

Six months after the passage of health care reform, it is easy to forget how far we have come in such a short time. It will take years to make the law's most important changes.

8 Oct 2010

Researchers explain nano-topographical responsiveness of stem cells

Many scientists aspire to take control over the stem cell differentiation process, so that we can grow organs and implants perfectly matched to each patient in the future. Now research in the Journal of Tissue Engineering, published by SAGE-Hindawi, explains how engineering the topography on which stem cells grow, and the mechanical forces working on them, can be as powerful an agent for change as their chemical environment.

8 Oct 2010

International scientific conference explores new approaches to prevent infectious diseases

Swine flu, cancer, bioterrorism and the latest trends in countermeasures to combat these life-threatening diseases and infections are among the topics to be discussed at the upcoming New Cells for New Vaccines V: Global Perspectives international scientific conference, on October 11-13 in Wilmington, Delaware, at the Hotel du Pont.

8 Oct 2010

Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study

NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.

8 Oct 2010

ISCO to present data on Hepatocyte-like cells at ASSLD Annual Meeting

International Stem Cell Corporation, will present data on its progress toward producing human liver cells from immune-matched patient-specific parthenogenetic stem cells at The Liver Meeting, the 61st Annual Meeting of the American Association for the Study of Liver Diseases (ASSLD), in Boston, MA from October 29 - November 2, 2010.

8 Oct 2010

Michigan judge rules individual mandate in health law is constitutional

"A U.S. judge on Thursday upheld a key part of President Barack Obama's signature healthcare law that requires Americans to obtain coverage, rejecting a challenge by a conservative interest group. The Thomas More Law Center filed a lawsuit in Michigan the day Obama signed it into law. It argued that the provision requiring Americans buy coverage by 2014 under threat of penalty was beyond Congress' authority and an unconstitutional tax" (Pelofsky, 10/7).

8 Oct 2010

New imaging technique may help in early detection of prostate cancer

Prostate cancer -- the most common cancer afflicting American men -- may be effectively diagnosed at an early stage without ionizing radiation, using a non-invasive imaging technique known as contrast-enhanced ultrasound (CEUS), according to a report announced late last week at the 25th Annual Advances in Contrast Ultrasound - ICUS Bubble Conference in Chicago.

8 Oct 2010

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Inviragen and PharmaJet announced the award of a five year, $15.5 million dollar contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to advance the development of a needle-free, easy to administer dengue vaccine. The award will fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen's tetravalent dengue vaccine, DENVax delivered with PharmaJet's convenient needle-free injection device.

8 Oct 2010

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Heart muscle cells do not normally replicate in adult tissue, but multiply with abandoned during development. This is why the loss of heart muscle after a heart attack is so dire-you can't grow enough new heart muscle to make up for the loss.

8 Oct 2010

Medical researchers take the next step in personalized medicine

Prescription drugs and their dosages may be standardized, but not every patient reacts to a medicine in the same way. The personal genetic characteristics of individuals and populations can explain why a specific prescription successfully treats one patient and not another, so medical researchers are adopting the new approach called "personalized medicine" and a Tel Aviv University lab is leading the way.

8 Oct 2010

Increased global attention, research needs to be given to stroke prevention: UEA

Increased global attention and research needs to be given to stroke prevention and the social and economic effects of the condition in developing countries, according to an academic at the University of East Anglia.

8 Oct 2010

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

Profectus BioSciences, Inc., a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases, today announced that it has received $6.25M in National Institute of Allergy and Infectious Disease (NIAID) grants and contracts.

8 Oct 2010

Insurer funds business PAC supporting Calif. GOP insurance commissioner candidate, other health politics

A California Chamber of Commerce political action committee bankrolled in part by insurance companies is funding TV ads supporting Republican Mike Villines in his quest to become state insurance commissioner, the Los Angeles Times reports.

8 Oct 2010

Genzyme board of directors vote to reject tender offer from Sanofi-Aventis

Genzyme Corp. announced today that its board of directors has voted unanimously to reject the unsolicited $69.00 per share tender offer from Sanofi-Aventis, and the board recommends that Genzyme shareholders not tender their shares to Sanofi-Aventis pursuant to the offer.

8 Oct 2010

FDA files complaint for permanent injunction against Brooklyn Juice Company

At the request of the U.S. Food and Drug Administration, the U.S. Department of Justice today filed a complaint for permanent injunction against a Brooklyn juice company to prevent it from processing and distributing juice products.

8 Oct 2010

AHRQ awards $1.2M grant to evaluate effectiveness of primary care transformation efforts

The Department of Health and Human Services Agency for Healthcare Research and Quality has awarded a $1.2 million grant to Michigan State University to evaluate the effectiveness of primary care transformation efforts at Priority Health and Independent Health, a New York plan.

8 Oct 2010

USPTO issues Patent Notice of Allowance for CIP-TRAMADOL ER drug

Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.

8 Oct 2010

Medical News

Patient personality can cause missed diagnoses of depression

NIAID announces three new contracts to fund research on dengue, anthrax vaccines

New standards for bomb suits

Opeds: Editorials weigh in on success -- or not -- of 'Obama's' health reform

Researchers explain nano-topographical responsiveness of stem cells

International scientific conference explores new approaches to prevent infectious diseases

Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study

ISCO to present data on Hepatocyte-like cells at ASSLD Annual Meeting

Michigan judge rules individual mandate in health law is constitutional

New imaging technique may help in early detection of prostate cancer

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Medical researchers take the next step in personalized medicine

Increased global attention, research needs to be given to stroke prevention: UEA

NIAID awards $6.25M to Profectus to optimize portfolio of genetic adjuvants

Insurer funds business PAC supporting Calif. GOP insurance commissioner candidate, other health politics

Genzyme board of directors vote to reject tender offer from Sanofi-Aventis

FDA files complaint for permanent injunction against Brooklyn Juice Company

AHRQ awards $1.2M grant to evaluate effectiveness of primary care transformation efforts

USPTO issues Patent Notice of Allowance for CIP-TRAMADOL ER drug

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News